Trials / Not Yet Recruiting
Not Yet RecruitingNCT07326631
Finerenone for Cardiorenal Protection in Diabetic CKD: Impact on Renal Function Decline and Heart Failure
- Status
- Not Yet Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 120 (estimated)
- Sponsor
- College of Physicians and Surgeons Pakistan · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To assess the effect of Finerinone on slowing renal function decline and improving cardiovascular outcomes, particularly heart failure risk, in patients with diabetic CKD.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Finerenone | To assess the effect of Finerinone on slowing renal function decline and improving cardiovascular outcomes, particularly heart failure risk, in patients with diabetic CKD. |
Timeline
- Start date
- 2026-01-01
- Primary completion
- 2026-06-30
- Completion
- 2026-07-01
- First posted
- 2026-01-08
- Last updated
- 2026-01-08
Source: ClinicalTrials.gov record NCT07326631. Inclusion in this directory is not an endorsement.